TynanDx was born out of many years of experience developing products and bringing them to market. We truly believe that better clinical diagnostic data leads to the efficient delivery of health care.

Our vision is to bring our technical know-how, our commercial knowledge and our strategic insights to guide you as you invest in development and commercialization of clinical diagnostics.

Our principals have worked with diagnostics products:

  • In multiple clinical areas including solid tumors and hematological cancers, prenatal genetics, inherited genetic diseases, infection disease, and cardiovascular and companion diagnostics.
  • Across multiple platforms including next gen sequencing, molecular diagnostics, immunoassays, immunohistochemistry and multivariate analyte-based algorithmic assays.
  • For both CLIA lab settings and FDA-cleared products to be used in hospitals labs and point-of-care

This experience gives us a well-rounded perspective of the environment in which our clients operate.